MyFinsight
Home
Blog
About
Accounts receivable, net
of allowances of...
$6,786K
(-12.36%↓ Y/Y)
Cash and cash
equivalents
$4,413K
(-56.75%↓ Y/Y)
Inventories - net
$3,686K
(-0.65%↓ Y/Y)
Prepaid expenses and
other current assets
$852K
(-35.94%↓ Y/Y)
Total current assets
$15,737K
(-31.54%↓ Y/Y)
Right-of-use asset
$10,612K
(-5.44%↓ Y/Y)
Property and equipment -
net
$7,172K
(-15.28%↓ Y/Y)
Patents - net
$2,864K
(-23.40%↓ Y/Y)
Restricted cash
$1,522K
(0.00%↑ Y/Y)
Other assets
$53K
(-98.60%↓ Y/Y)
Total assets
$37,960K
(-20.90%↓ Y/Y)
Accumulated deficit
-$321,754K
(-6.00%↓ Y/Y)
Accumulated other
comprehensive loss
-$996K
(74.85%↑ Y/Y)
Total liabilities and
stockholders' equity...
$37,960K
(-20.90%↓ Y/Y)
Total stockholders'
equity (deficit)
-$751K
(-106.48%↓ Y/Y)
Additional paid-in capital
$321,936K
(0.91%↑ Y/Y)
Common stock, par value
0.001, 100,000,000...
$63K
(0.00%↑ Y/Y)
Total liabilities
$38,711K
(6.34%↑ Y/Y)
Total current
liabilities
$24,023K
(144.09%↑ Y/Y)
Lease liability, net
of current portion
$11,596K
(-4.83%↓ Y/Y)
Long-term debt, net of
current portion and debt...
$3,092K
(-78.49%↓ Y/Y)
Current maturities of
long-term debt, net of debt...
$14,149K
Accrued expenses and
other current...
$7,283K
(22.34%↑ Y/Y)
Accounts payable
$2,002K
(-41.01%↓ Y/Y)
Lease liability -
current portion
$589K
(18.99%↑ Y/Y)
Back
Back
Balance Sheet
Cytosorbents Corp (CTSO)
Cytosorbents Corp (CTSO)
source: myfinsight.com